Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Oxaliplatin × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 34 Stomach Neoplasms 27 Rectal Neoplasms 15 Pancreatic Neoplasms 14 Lymphoma, Large B-Cell, Diffuse 14 Colonic Neoplasms 13 Esophageal Neoplasms 12 Adenocarcinoma Of Esophagus 9 Carcinoma, Non-Small-Cell Lung 8 Adenocarcinoma 8 Neoplasms 7 Neoplasm Metastasis 7 Cholangiocarcinoma 7 Ovarian Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Lymphoma 4 Biliary Tract Neoplasms 4 Lung Neoplasms 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Advanced Solid Tumors 3 Triple Negative Breast Neoplasms 2 Pathologic Complete Response 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Locally Advanced Rectal Cancer 2 HER2-positive Gastric Cancer 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Colorectal Adenocarcinoma 2

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡